268 related articles for article (PubMed ID: 22981865)
1. Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells.
Kallin EM; Rodríguez-Ubreva J; Christensen J; Cimmino L; Aifantis I; Helin K; Ballestar E; Graf T
Mol Cell; 2012 Oct; 48(2):266-76. PubMed ID: 22981865
[TBL] [Abstract][Full Text] [Related]
2. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages.
Barneda-Zahonero B; Román-González L; Collazo O; Rafati H; Islam AB; Bussmann LH; di Tullio A; De Andres L; Graf T; López-Bigas N; Mahmoudi T; Parra M
PLoS Genet; 2013 May; 9(5):e1003503. PubMed ID: 23696748
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.
Pronier E; Almire C; Mokrani H; Vasanthakumar A; Simon A; da Costa Reis Monte Mor B; Massé A; Le Couédic JP; Pendino F; Carbonne B; Larghero J; Ravanat JL; Casadevall N; Bernard OA; Droin N; Solary E; Godley LA; Vainchenker W; Plo I; Delhommeau F
Blood; 2011 Sep; 118(9):2551-5. PubMed ID: 21734233
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha (C/EBP(alpha))-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation.
Di Tullio A; Vu Manh TP; Schubert A; Castellano G; Månsson R; Graf T
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17016-21. PubMed ID: 21969581
[TBL] [Abstract][Full Text] [Related]
5. TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2
Li R; Zhou Y; Cao Z; Liu L; Wang J; Chen Z; Xing W; Chen S; Bai J; Yuan W; Cheng T; Xu M; Yang FC; Zhao Z
Stem Cell Reports; 2018 Jan; 10(1):166-179. PubMed ID: 29290626
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
7. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A
Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493
[TBL] [Abstract][Full Text] [Related]
8. TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells.
Garcia-Gomez A; Li T; Kerick M; Català-Moll F; Comet NR; Rodríguez-Ubreva J; de la Rica L; Branco MR; Martín J; Ballestar E
Nucleic Acids Res; 2017 Sep; 45(17):10002-10017. PubMed ID: 28973458
[TBL] [Abstract][Full Text] [Related]
9. TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.
Langlois T; da Costa Reis Monte-Mor B; Lenglet G; Droin N; Marty C; Le Couédic JP; Almire C; Auger N; Mercher T; Delhommeau F; Christensen J; Helin K; Debili N; Fuks F; Bernard OA; Solary E; Vainchenker W; Plo I
Stem Cells; 2014 Aug; 32(8):2084-97. PubMed ID: 24723429
[TBL] [Abstract][Full Text] [Related]
10. TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.
Liang Y; Zeng J; Luo B; Li W; He Y; Zhao W; Hu N; Jiang N; Luo Y; Xian Y; Liu J; Zheng X
Mol Immunol; 2020 Oct; 126():136-142. PubMed ID: 32823238
[TBL] [Abstract][Full Text] [Related]
11. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
[TBL] [Abstract][Full Text] [Related]
12. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
[TBL] [Abstract][Full Text] [Related]
13. Frontline Science: Cxxc5 expression alters cell cycle and myeloid differentiation of mouse hematopoietic stem and progenitor cells.
Joshi HR; Hill HR; Zhou Z; He X; Voelkerding KV; Kumánovics A
J Leukoc Biol; 2020 Aug; 108(2):469-484. PubMed ID: 32083332
[TBL] [Abstract][Full Text] [Related]
14. C/EBPα Activates Pre-existing and De Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis.
van Oevelen C; Collombet S; Vicent G; Hoogenkamp M; Lepoivre C; Badeaux A; Bussmann L; Sardina JL; Thieffry D; Beato M; Shi Y; Bonifer C; Graf T
Stem Cell Reports; 2015 Aug; 5(2):232-47. PubMed ID: 26235892
[TBL] [Abstract][Full Text] [Related]
15. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
[TBL] [Abstract][Full Text] [Related]
16. Tet2 restrains inflammatory gene expression in macrophages.
Cull AH; Snetsinger B; Buckstein R; Wells RA; Rauh MJ
Exp Hematol; 2017 Nov; 55():56-70.e13. PubMed ID: 28826859
[TBL] [Abstract][Full Text] [Related]
17. C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.
Rodriguez-Ubreva J; Ciudad L; van Oevelen C; Parra M; Graf T; Ballestar E
Mol Cell Biol; 2014 Mar; 34(6):1145-57. PubMed ID: 24421386
[TBL] [Abstract][Full Text] [Related]
18. Cebpα is essential for the embryonic myeloid progenitor and neutrophil maintenance in zebrafish.
Dai Y; Zhu L; Huang Z; Zhou M; Jin W; Liu W; Xu M; Yu T; Zhang Y; Wen Z; Liao W; Zhang W
J Genet Genomics; 2016 Oct; 43(10):593-600. PubMed ID: 27751705
[TBL] [Abstract][Full Text] [Related]
19. Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.
Zhong X; Wang QQ; Li JW; Zhang YM; An XR; Hou J
Sci Rep; 2017 Mar; 7():43539. PubMed ID: 28272491
[TBL] [Abstract][Full Text] [Related]
20. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
